Serotonin and norepinephrine reuptake inhibition and eating behavior (Q34587982)

3 August 2017

1 reference

title

Serotonin and norepinephrine reuptake inhibition and eating behavior (English)

1 reference

3 August 2017

0 references

0 references

4

Marie Kunesova

1 reference

3 August 2017

Vojtech Hainer

1

1 reference

3 August 2017

Karolina Kabrnova

series ordinal

2

1 reference

3 August 2017

Bashar Aldhoon

series ordinal

3

1 reference

3 August 2017

Martin Wagenknecht

series ordinal

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Annals of the New York Academy of Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

1083

1 reference

3 August 2017

page(s)

252-269

1 reference

International trial of long-term dexfenfluramine in obesity.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Sex differences in cortisol response to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Profound weight loss associated with reboxetine use in a 44-year-old woman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Depression and anxiety symptoms in relation to anthropometry and metabolism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

21 January 2018

Depression and obesity

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Obesity and depression: same disease, different names?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The within-pair resemblance in serum levels of androgens, sex-hormone binding globulin and cortisol in female obese identical twins - effect of negative energy balance induced by very low-calorie diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Depression and coronary heart disease in women with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Cortisol secretion in relation to body fat distribution in obese premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Symptom fluctuation in bulimia nervosa: relation to menstrual-cycle phase and cortisol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Self-destructiveness and serotonin function in bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Cortisol stress response is positively correlated with central obesity in obese women with binge eating disorder (BED) before and after cognitive-behavioral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Pharmacological approaches in the treatment of binge eating disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The night-eating syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The night eating syndrome: a progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Sibutramine in clinical practice - a PMS-study with positive effects on blood pressure and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Long-term weight loss with sibutramine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Safety pharmacology of sibutramine mesylate, an anti-obesity drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

Preoperative Eating Behavior and Weight-loss Following Gastric Banding for Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

The Eating Inventory, body adiposity and prevalence of diseases in a quota sample of Czech adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

A twin study of dietary restraint, disinhibition and hunger: an examination of the eating inventory (three factor eating questionnaire).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

GAD2 on chromosome 10p12 is a candidate gene for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1367.017

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1367.017

1 reference

3 August 2017

1 reference